Drug intelligence / Profile preview

Nerviheal OD

Development stage
Unknown
Lead developer
Heal All Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Nerviheal OD is an oral nutraceutical softgel capsule developed by Heal All Pharmaceuticals for the management of diabetic and drug-induced neuropathy, as well as cardiovascular complications associated with high oxidative stress. It is a multi-ingredient combination containing methylcobalamin (1500 mcg), alpha-lipoic acid (100 mg), folic acid (1.5 mg), vitamin B6 (1.5 mg), chromium picolinate (500 mcg), sodium selenite (75 mcg), and zinc sulfate monohydrate (7.5 mg). Methylcobalamin (an active form of Vitamin B12) and vitamin B6 support nerve regeneration and myelin sheath formation, while alpha-lipoic acid acts as a potent antioxidant to reduce oxidative stress in nerve tissues. Folic acid, chromium, selenium, and zinc provide essential nutritional support to improve nerve conduction and metabolic function.

Brand names
Nerviheal ODNerviheal-OD
Other names
alpha-lipoic acid + chromium + folic acid + methylcobalamin + pyridoxine + selenium + zincalpha-lipoic acid + chromium picolinate + folic acid + methylcobalamin + pyridoxine + sodium selenite + zinc sulfate
02

Targets

MTR (Methionine synthase)

Beyond the preview

Go deeper on Nerviheal OD.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nerviheal OD.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call